Methylenetetrahydrofolate reductase polymorphism associated with moderate hyperhomocysteinaemia in a patient with livedo vasculopathy: treatment with vitamin supplementation and low molecular weight heparin.
Rampf
J
J
Sunderkötter
C
C
Hirschfeld
G
G
Scharffetter-Kochanek
K
K
Weiss
J M
JM
D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D020138:Hyperhomocysteinemia / Q000235:genetics*; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D011110:Polymorphism, Genetic; D017445:Skin Diseases, Vascular / Q000235:genetics*; D014815:Vitamins / Q000627:therapeutic use
D006495:Heparin, Low-Molecular-Weight; D014815:Vitamins; D042965:Methylenetetrahydrofolate Reductase (NADPH2)